uk-fficm MCQ (SBA): Amiodarone Pulmonary Toxicity

Instant feedback + full explanation. One question, done properly.

ModeratePharmacology & PrescribingAmiodarone Pulmonary Toxicityuk-fficm

A 55-year-old woman on ICU is receiving IV amiodarone for new-onset atrial fibrillation. She develops acute breathlessness and a new ground-glass opacity on CXR. CT shows diffuse bilateral ground-glass changes with areas of consolidation. BAL shows a mixed inflammatory infiltrate with foamy macrophages. Eosinophils are mildly elevated. Drug-induced lung toxicity is suspected. What is the most likely diagnosis?

Educational content. Not a substitute for clinical judgement or local policy.

uk-fficm MCQ: Amiodarone Pulmonary Toxicity — Answer & Explanation | i